Riskpilot← Back to searchSign inGet full accessORACAIN II ApS
APSDissolvedCVR 33492707Bryggen 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 20111 employees
Revenue 2023
DKK -19K
-73% vs 2022
EBITDA margin
100.0%
+73% vs 2022
Equity ratio
-15.9%
Financial strength
Net profit 2023
DKK -493K
-238% vs 2022
| Revenue | DKK -19K | -73% |
| EBITDA | DKK -19K | +73% |
| Net profit | DKK -493K | -238% |
| Total assets | DKK 263K | -54% |
| Equity | DKK -42K | -109% |
| Employees | 1 | — |
Legal name
ORACAIN II ApS
CVR number
33492707
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25. januar 2011
Share capital
DKK 131.851
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med direktøren eller af bestyrelsesformanden i forening med et andet bestyrelsesmedlem.
Address
Bryggen 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | -28 | -37 | -40 | -30 | -20 | -17 | -69 | -19 |
| Staff expenses | -0 | -0 | -0 | -0 | -243 | -174 | -123 | -71 | -0 | -0 | -0 | -0 |
| EBITDA | -335 | -326 | -2.151 | -295 | -271 | -211 | -163 | -602 | -20 | -1 | -69 | -19 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -335 | -326 | -2.151 | -295 | -271 | -211 | -163 | -602 | -20 | -1 | -69 | -19 |
| Net financials | 7 | 0 | -0 | 12 | 12 | 14 | 5 | 11 | -128 | 115 | 379 | -474 |
| Profit before tax | -328 | -326 | -2.151 | -283 | -259 | -197 | -158 | -591 | -148 | 114 | 310 | -493 |
| Tax | -0 | -32 | -766 | -159 | 645 | -0 | 11 | -0 | -0 | -0 | -47 | -0 |
| Net profit | -328 | -294 | -1.385 | -124 | -904 | -197 | -169 | -591 | -148 | 114 | 357 | -493 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.848 | 3.834 | 2.196 | 2.052 | 1.166 | 999 | 849 | 151 | 3 | 135 | 569 | 263 |
| Equity | 3.792 | 3.498 | 2.113 | 1.990 | 1.085 | 889 | 719 | 128 | -20 | 94 | 451 | -42 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 56 | 62 | 82 | 63 | 81 | 110 | 129 | 23 | 23 | 41 | 118 | 305 |
| Total debt | 56 | 62 | 82 | 63 | 81 | 110 | 129 | 23 | 23 | 41 | 118 | 305 |
EBITDA margin
-1872900.0%
This company
15.8%
Market median
-11853897% vs market
20122023
Equity ratio
-15.9%
This company
38.2%
Market median
-142% vs market
20122023
Return on equity
-49264800.0%
This company
18.4%
Market median
-267743578% vs market
20122023
Net profit margin
-49264800.0%
This company
8.1%
Market median
-608207507% vs market
20122023
Asset turnover
-0.07×
This company
1.12×
Market median
-106% vs market
20122023
Debt / equity
7.29×
This company
0.62×
Market median
-1076% vs market
20122023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BB Management | Management | 2011 | — | — |
BT Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
AK Unofficial title | Unofficial title | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 0.0% | 0.0% | 2013 | |
ORACAIN ApS | Company | 90.0% | 90.0% | 2013 |
PreSeed Ventures A/S | Company | 25.0% | 25.0% | 2011 |
SEED CAPITAL DENMARK II K/S | Company | 5.0% | 5.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORACAIN II ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarne Bymose | Management | 0 companies |
| Betina Thorball | Chief Executive Officer | 0 companies |
| Andreas Kærsgaard Mylin | Unofficial title | 0 companies |
| Ove Andersen | Chairman | 0 companies |
| Michael Alstrøm | Board of Directors | 0 companies |
| Line Holten Reimer | Board of Directors | 0 companies |
| Torben Steen Mogensen | Board of Directors | 0 companies |